Microwave assisted synthesis, cholinesterase enzymes inhibitory activities and molecular docking studies of new pyridopyrimidine derivatives

被引:38
作者
Basiri, Alireza [1 ]
Murugaiyah, Vikneswaran [1 ]
Osman, Hasnah [2 ]
Kumar, Raju Suresh [3 ]
Kia, Yalda [2 ]
Ali, Mohamed Ashraf [4 ]
机构
[1] Univ Sains Malaysia, Sch Pharmaceut Sci, Minden 11800, Penang, Malaysia
[2] Univ Sains Malaysia, Sch Chem Sci, Minden 11800, Penang, Malaysia
[3] King Saud Univ, Coll Sci, Dept Chem, Riyadh 11451, Saudi Arabia
[4] Univ Sains Malaysia, Inst Res Mol Med, Minden 11800, Penang, Malaysia
关键词
Microwave assisted synthesis; Pyridopyrimidines; AChE and BChE activity; Molecular docking; ALZHEIMERS-DISEASE; ACETYLCHOLINESTERASE; BUTYRYLCHOLINESTERASE; HYPOTHESIS; THERAPY; TORPEDO;
D O I
10.1016/j.bmc.2013.03.058
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of hitherto unreported pyrido-pyrimidine-2-ones/pyrimidine-2-thiones were synthesized under microwave assisted solvent free reaction conditions in excellent yields and evaluated in vitro for their acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzymes inhibitory activity. Among the pyridopyrimidine derivatives, 7e and 7l displayed 2.5- and 1.5-fold higher enzyme inhibitory activities against AChE as compared to standard drug, galanthamine, with IC50 of 0.80 and 1.37 mu M, respectively. Interestingly, all the compounds except 6k, 7j and 7k displayed higher inhibitory potential against BChE enzyme in comparison to standard with IC50 ranging from 1.18 to 18.90 mu M. Molecular modeling simulations of 7e and 7l was performed using three-dimensional structure of Torpedo californica AChE (TcAChE) and human butyrylcholinesterase (hBChE) enzymes to disclose binding interaction and orientation of these molecule into the active site gorge of respective receptors. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3022 / 3031
页数:10
相关论文
共 29 条
[2]   SUBSTITUTED 1,4-DIHYDROPYRIMIDINES .3. SYNTHESIS OF SELECTIVELY FUNCTIONALIZED 2-HETERO-1,4-DIHYDROPYRIMIDINES [J].
ATWAL, KS ;
ROVNYAK, GC ;
OREILLY, BC ;
SCHWARTZ, J .
JOURNAL OF ORGANIC CHEMISTRY, 1989, 54 (25) :5898-5907
[3]  
Batsch N. L., 2012, World Alzheimer report 2012: Overcoming the stigma of dementia
[4]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[5]   Synthesis and biological activity of analogues of ptilomycalin A [J].
Black, GP ;
Coles, SJ ;
Hizi, A ;
Howard-Jones, AG ;
Hursthouse, MB ;
McGown, AT ;
Loya, S ;
Moore, CG ;
Murphy, PJ ;
Smith, NK ;
Walshe, NDA .
TETRAHEDRON LETTERS, 2001, 42 (19) :3377-3381
[6]   A conformational and structure-activity relationship study of cytotoxic 3,5-bis(arylidene)-4-piperidones and related N-acryloyl analogues [J].
Dimmock, JR ;
Padmanilayam, MP ;
Puthucode, RN ;
Nazarali, AJ ;
Motaganahalli, NL ;
Zello, GA ;
Quail, JW ;
Oloo, EO ;
Kraatz, HB ;
Prisciak, JS ;
Allen, TM ;
Santos, CL ;
Balzarini, J ;
De Clercq, E ;
Manavathu, EK .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (04) :586-593
[7]   Cholinesterase inhibitors: new roles and therapeutic alternatives [J].
Giacobini, E .
PHARMACOLOGICAL RESEARCH, 2004, 50 (04) :433-440
[8]   Cholinesterase inhibitors for Alzheimer's disease therapy: from tacrine to future applications [J].
Giacobini, E .
NEUROCHEMISTRY INTERNATIONAL, 1998, 32 (5-6) :413-419
[9]   Selective inhibitors of butyrylcholinesterase - A valid alternative for therapy of Alzheimer's disease? [J].
Giacobini, E .
DRUGS & AGING, 2001, 18 (12) :891-898
[10]  
Giacobini E., 2000, CHOLINESTERASES CHOL, P181